Olaparib (O) in patients (pts) with pancreatic cancer with BRCA1/2 inactivating mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
Conference Paper
Full Text
Duke Authors
Cited Authors
- Ahn, ER; Garrett-Mayer, E; Halabi, S; Mangat, PK; Calfa, CJ; Alva, AS; Suhag, VS; Hamid, O; Dotan, E; Yang, ES-H; Alese, OB; Yost, KJ; Marr, AS; Palmer, MC; Thompson, FL; Rygiel, AL; Anderson, ST; Islam, S; Schilsky, RL
Published Date
- May 20, 2020
Published In
Volume / Issue
- 38 / 15
Electronic International Standard Serial Number (EISSN)
- 1527-7755
International Standard Serial Number (ISSN)
- 0732-183X